| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |